PATENT CLAIM ANALYSIS

Application Number: 16006465
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "048000"]

Abstract:
A cyclic dinucleotide compound of Formula (I): wherein X 1  is H or F; X 2  is H or F; at least one among X 1  and X 2  is a fluorine atom; Z is OH, OR 1 , SH or SR 1 , wherein: R 1  is Na or NH 4 , or R 1  is an enzyme-labile group which provides OH or SH in vivo such as pivaloyloxymethyl; B 1  and B 2  are bases chosen from Adenine, Hypoxanthine or Guanine, and B 1  is a different base than B 2  and a pharmaceutically acceptable salt thereof. Pharmaceutical compositions including the cyclic dinucleotide, as well as their use in the treatment of a bacterial infection, a viral infection or a cancer are also described.

Claim (Index 21):
The cyclic dinucleotide of Formula (II) according to  claim 15 , wherein X 1  and X 2  are not a fluorine atom.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.83117
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15034335', '14280667', '15665378', '15898533', '15411850']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6949247912913975
- 35 USC 102 Novelty (BERT): 0.5706215823438482
- Combined Prediction Score: 0.6824944703966427
- Mean Citation Score: 304.69098
- Max Citation Score: 561.9469
- Similarity Product: 318.20174347509146

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test